Atlas Trials

A Clinical Trial With Apatinib for Subjects With Refractory Malignant Ascites

Clinical trial NCT03020979 · UNKNOWN

Trial details

NCT number
NCT03020979
Sponsor
The First Affiliated Hospital of Bengbu Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant AscitesApatinib
Start date
2017-01-01
Primary completion
2018-12-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.